Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Glaxo Smith Kline Promises Increased Transparency

Filed October 16th, 2012 Laurie

GlaxoSmithKline (GSK) has promised to make its clinical trial data available to the scientific community as part of its efforts to provide increased transparency and cooperation.

GSK was fined $3 billion in the United States for concealing safety issues. The drug maker pleaded guilty in July 2012 to promoting the drugs Paxil and Wellbutrin for unapproved uses. GSK also withheld safety data regarding the diabetes drug, Avandia, from the U.S. Food & Drug Administration (FDA), Medical News Today said.

The $3 billion settlement covered criminal fines and civil settlements with state and federal governments and involved 10 medications, including Advair, Avandia, Wellbutrin, and Paxil, according to Medical News Today. GSK was also found guilty of bribing doctors.

GSK says that its web site–The GlaxoSmithKline Clinical Study Register–now includes the result of summaries from as many as 4,500 clinical trials. The company also plans to publish the results of all clinical trials that evaluate its medications, regardless of the findings, to peer-reviewed academic journals, Medical News Today noted.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!